Immunohistochemical detection of p53 tumor suppressor protein in porokeratosis

Journal of Dermatology

Volumn 23, Issue 5, 1996, Pages 365-368

  Urano, Yoshio ^a   Sasaki, Shiro ^a   Ninomiya, Yoshiro ^a   Oura, Hajimu ^a   Arase, Seiji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

carcinogenesis; immunohistochemistry; overexpression; p53; porokeratosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ELECTROCHEMICAL DETECTION; EPIDERMIS; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINIZATION; MALE; PARAKERATOSIS; POROKERATOSIS; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0029943498     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb04033.x     Document Type: Article

References (25)

1. Lever WF, Schaumburg-Lever G: Histopathology of the Skin, 7th ed, JB Lippincott, Philadelphia, 1990, pp 70-72.
2. Griffiths WAD, Leigh IM, Marks R: Disorders of keratinization, in Champion RH, Burton JL, Ebling FJG (eds): Textbook of Dermatology, 5th ed, Vol. 2, Blackwell Scientific Publications, Oxford, 1992, p 1325.
3. Goerttler EA, Jung EG: Parakeratosis Mibelli and skin carcinoma, Humangenetik, 26: 291-296, 1975.
4. Otsuka F, Someya T, Ishibashi Y: Porokeratosis and malignant skin tumors, J Cancer Res Clin Oncol, 117: 55-60, 1991.
5. Ruocco V, Satriano RA, Florio M, Pettinato G, Pisani M: Porokeratosis palmaris et plantaris disseminata with squamous cell carcinoma, G Ital Dermatol Venereol, 125: 53-58, 1990.
6. Reed RJ, Leone P: Porokeratosis - A mutant clonal keratosis of the epidermis, I. Histogenesis, Arch Dermatol, 101: 340-347, 1970.
7. Magee JW, McCalmont TH, LeBoit PE: Overexpression of p53 tumor suppressor protein in porokeratosis, Arch Dermatol, 130: 187-190, 1994.
8. Puig L, Alegre M, Costa I, Matías-Guiu X, de Moragas JM: Overexpression of p53 in disseminated superficial actinic porokeratosis with and without malignant degeneration, Arch Dermatol, 131: 353-354, 1995.
9. Kanitakis J, Misery L, Nicolas JF, et al: Disseminated superficial porokeratosis in a patient with AIDS, Br J Dermatol, 131: 284-289, 1994.
10. Sasaki S, Urano Y, Nakagawa K, Nagae H, Nakanishi H, Arase S: Linear porokeratosis with multiple squamous cell carcinomas: Study of p53 expression in porokeratosis and squamous cell carcinoma, Br J Dermatol. (in press)
11. Urano Y, Asano T, Yoshimoto K, et al: Frequent p53 accumulation in the chronically sun-exposed epidermis and clonal expansion of p53 mutant cells in the epidermis adjacent to basal cell carcinoma, J Invest Dermatol, 104: 928-932, 1995.
12. Nagano T, Ueda M, Ichihashi M: Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis, Arch Dermatol, 129: 1157-1161, 1993.
13. Urano Y, Oura H, Sakaki A, et al: Immunohistological analysis of p53 expression in human skin tumors, J Dermatol Sci, 4: 69-75, 1992.
14. Slater SD, McGrath JA, Hobbs C, Eady RAJ, McKee PH: Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa, Histopathology, 20: 237-241, 1992.
15. McNutt NS, Saenz-Santamaria C, Volkenandt M, Shea CR, Albino AP: Abnormalities of p53 protein expression in cutaneous disorders, Arch Dermatol, 130: 225-232, 1994.
16. Otsuka F, Shima A, Ishibashi Y: Porokeratosis as a premalignant condition of the skin. Cytologic demonstration of abnormal DNA ploidy in cells of the epidermis, Cancer, 63: 891-896, 1989.
17. Taylor AMR, Harnden DG, Fairburn EA: Chromosomal instability associated with susceptibility to malignant disease in patients with porokeratosis of Mibelli, J Natl Cancer Inst, 51: 371-378, 1973.
18. Machino H, Miki Y, Teramoto T, Shiraishi S, Sasaki MS: Cytogenetic studies in a patient with porokeratosis of Mibelli, multiple cancers and a forme fruste of Werner's syndrome, Br J Dermatol, 111: 579-586, 1984.
19. Watanabe R, Ishibashi Y, Otsuka F: Chromosomal instability and cellular hypersensitivity to X-radiation of cultured fibroblasts derived from porokeratosis patients' skin, Mutat Res, 230: 273-278, 1990.
20. Hartwell L: Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells, Cell, 71: 543-546, 1992.
21. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage, Cancer Res, 51: 6304-6311, 1991.
22. Iggo R, Gatter K, Bartek J, Lane D, Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer, Lancet, 335: 675-679, 1990.
23. Barnes DM, Hanby AM, Gillett CE, et al: Abnormal expression of wild type p53 protein in normal cells of a cancer family patient, Lancet, 340: 259-263, 1992.
24. Campbell C, Quinn AG, Angus B, Rees JL: The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer, Br J Dermatol, 129: 235-241, 1993.
25. Kubo Y, Urano Y, Yoshimoto K, et al: p53 gene mutations in human skin cancers and precancerous lesions: Comparison with immunohistochemical analysis, J Invest Dermatol, 102: 440-444, 1994.